BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16954316)

  • 1. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
    Somsak V; Uthaipibull C; Prommana P; Srichairatanakool S; Yuthavong Y; Kamchonwongpaisan S
    Malar J; 2011 Oct; 10():291. PubMed ID: 21981896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
    O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
    J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the role of mutations in Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene using an episomal Plasmodium falciparum transfection system.
    Auliff AM; Adams JH; O'Neil MT; Cheng Q
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3927-32. PubMed ID: 20566761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum.
    Auliff AM; Balu B; Chen N; O'Neil MT; Cheng Q; Adams JH
    PLoS One; 2012; 7(7):e40416. PubMed ID: 22792308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
    Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
    Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
    Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.
    Leartsakulpanich U; Imwong M; Pukrittayakamee S; White NJ; Snounou G; Sirawaraporn W; Yuthavong Y
    Mol Biochem Parasitol; 2002 Jan; 119(1):63-73. PubMed ID: 11755187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites.
    Sardarian A; Douglas KT; Read M; Sims PF; Hyde JE; Chitnumsub P; Sirawaraporn R; Sirawaraporn W
    Org Biomol Chem; 2003 Mar; 1(6):960-4. PubMed ID: 12929634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.
    Rakmark K; Awab GR; Duanguppama J; Boonyuen U; Dondorp AM; Imwong M
    Malar J; 2020 Jul; 19(1):251. PubMed ID: 32664924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
    McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
    J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance.
    de Pécoulas PE; Tahar R; Ouatas T; Mazabraud A; Basco LK
    Mol Biochem Parasitol; 1998 May; 92(2):265-73. PubMed ID: 9657331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium vivax: rapid detection by polymerase chain reaction and restriction fragment length polymorphism of the key mutation in dihydrofolate reductase-thymidylate synthase gene associated with pyrimethamine resistance.
    Tahar R; de Pecoulas PE; Mazabraud A; Basco LK
    Exp Parasitol; 1998 Jul; 89(3):343-6. PubMed ID: 9676712
    [No Abstract]   [Full Text] [Related]  

  • 15. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.
    Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH
    Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
    Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
    Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence.
    Eldin de Pécoulas P; Basco LK; Tahar R; Ouatas T; Mazabraud A
    Gene; 1998 Apr; 211(1):177-85. PubMed ID: 9573357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
    Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
    Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
    Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
    J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors.
    Yuthavong Y; Yuvaniyama J; Chitnumsub P; Vanichtanankul J; Chusacultanachai S; Tarnchompoo B; Vilaivan T; Kamchonwongpaisan S
    Parasitology; 2005 Mar; 130(Pt 3):249-59. PubMed ID: 15796007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.